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We report on the analysis of the UL6 and UL7 open reading frames of the herpes simplex virus type 1 (HSV-1) genome. 
The UL6 and UL7 transcripts were identified in HSV-l-infected cells by Northern blotting and shown to be coterminal at 
their 3' ends. Both transcripts were synthesized in the presence of phosphonoacetic acid, although in reduced amounts, 
indicating that UL6 and UL7 are expressed as delayed-early or 1~-1 genes. The 5' ends of the two transcripts were mapped 
by $1 nuclease and primer extension analysis. A polyclonal antiserum directed against an Escherichia coli-expressed 6X 
His-UL6 fusion protein identified a protein of approximate Mr 75,000 in cells infected with either HSV-1 or with a vaccinia 
virus recombinant expressing the HSV-1 UL6 protein. As with the transcript, the UL6 protein was synthesized at reduced 
levels in the absence of viral DNA replication. Western immunoblotting showed that the UL6 protein was present in purified 
virions but not in L-particles of HSV-1, and that it was located exclusively in the tegument/capsid fraction of virion. Further 
analysis of the UL6 protein revealed that this protein was associated with virus capsids. ¢ 1995 Academic Press, Inc. 
INTRODUCTION 
Herpes simplex virus type 1 (HSV-1) virions contain a 
linear double-stranded DNA genome of approximately 
152 kbp, which is enclosed within an icosahedral capsid. 
The capsid is surrounded by an amorphous layer, termed 
the tegument, and an external glycoprotein-containing 
lipid envelope (reviewed by Dargan, 1986). In addition to 
infectious virions, noninfectious virion-related particles, 
termed L-particles, have been identified in HSV-1 prepa- 
rations (Szil~gyi and Cunningham, 1991). L-particles con- 
tain most of the envelope and tegument components of 
the virion but lack virus capsids and DNA (Szyl~gyi and 
Cunningham, 1991; McLauchlan and Rixon, 1992). Three 
types of capsid are seen in HSV-infected cells (Gibson 
and Roizman, 1972). Type A or empty capsids lack viral 
DNA and internal structure, type B or intermediate cap- 
sids also lack viral DNA but possess an internal protein- 
aceous scaffold, and type C or full capsids contain viral 
genomic DNA (reviewed by Rixon, 1993). Type B capsids 
are known to be composed of seven proteins which have 
been designated VP5, VP19C, VP21, VP22a, VP23, VP24, 
and VP26 (Gibson and Roizman, 1972; Heilman et aL, 
1979; Cohen et aL, 1980), and the genes to which these 
capsid proteins have been assigned are UL19, UL38, 
UL26, UL26.5, UL18, UL26, and UL35, respectively (Pres- 
ton et aL, 1983; Weller et aL, 1987; Pertuiset et aL, 1989; 
Rixon eta/., 1990; Liu and Roizman, 1991; Davison etaL, 
1992; McNabb and Courtney, 1992; Preston et aL, 1992). 
To whom reprint requests should be addressed. 
With the exception of the internal scaffolding proteins 
VP21 and VP22a, the protein composition of types A and 
C capsids is identical to that of type B capsids (see Rixon, 
1993). 
The genome of HSV-1 encodes at least 75 open read- 
ing frames (ORFs) (see McGeoch et aL 1993). Many of 
the ORFs and their potential products remain largely un- 
characterized. Two such ORFs, UL6 and UL7, are located 
near the left end of the long unique (UL) arm of the HSV- 
1 genome (McGeoch et aL, 1988). Nucleotide sequence 
analysis has shown that the two ORFs partially overlap 
each other, and it is predicted that the two genes encode 
transcripts that are coterminal at their 3' ends (McGeoch 
et aL, 1988). The ORFs UL6 and LJL7 code for proteins 
with predicted Mrs of 74,087 and 33,057, respectively. 
The UL6 gene is known to be essential for virus growth 
in tissue culture, whereas the status of UL7 is unknown. 
Two temperature-sensitive (ts) mutants carrying lesions 
in the UL6 gene have been isolated (Schaffer etaL, 1973; 
Weller etaL, 1987). Studies with one such mutant, tsF18, 
have shown that the UL6 gene product is required for the 
formation of full capsids (Sherman and Bachenheimer, 
1987). At nonpermissive temperature (NPT), the tsF18 
virus synthesizes near wild type levels of viral DNA but 
fails to cleave and package the replicated concatameric 
viral DNA, and it accumulates only type B capsids in 
infected cells (Sherman and Bachenheimer, 1987, 1988). 
The effect of the mutation is reversible upon shift to per- 
missive temperature but only after new protein and cap- 
sids are synthesized following the temperature shift, indi- 
cating that the viral DNA cleavage and its encapsidation 
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are tightly linked events (Sherman and Bachenheimer, 
1987, 1988). In addition to UL6, the gene products of 
UL25, UL28, and UL33 are required for processing and 
packaging of nascent viral DNA (Addison et aL, 1984, 
1990; AI-Kobaisi et aL, 1991; Tengelsen et aL, 1993), al- 
though the mechanisms involved in this process remain 
obscure. 
In the present study, we analyze the transcripts en- 
coded by the UL6 and UL7 genes of HSV-1 and define 
the precise location of their 5' ends. We also identify the 
UL6 gene product in HSV-l-infected cells and show that 
it is a component of infectious virions but not of L-parti- 
cles. Further characterization of the UL6 protein reveals 
that this protein is associated with virus capsids. 
MATERIALS AND METHODS 
Cells, viruses, and radioisotopic labeling 
HSV-1 strain 17 syn + (Brown eta/., 1973) and vaccinia 
virus strains WR and V-UL6 were propagated in baby 
hamster kidney (BHK) cells in Eagle's medium supple- 
mented with 2% newborn calf serum (EC2). Purified viri- 
ons and L-particles of HSV-1 strain F-derived UL46/47 
double-deletion mutant virus R(F)UL46/47z~2 were gen- 
erously provided by J. McLauchlan (this virus was origi- 
nally supplied by J. L. C. McKnight; Zhang and McKnight, 
1993). HSV-lambUL8, a viral DNA replication-negative 
mutant of HSV-1 strain 17 was grown in a complementing 
cell line A26= the construction of this virus and the cell 
line A26 will be described elsewhere (Patel and others, 
unpublished data). To biochemically inhibit viral DNA 
synthesis, cells were incubated 1 hr prior to and then 
throughout he infection in medium containing 300 #g/ml 
phosphonoacetic acid (PAA). Mock-infected and infected 
cells in 50-mm dishes were labeled with 50 #Ci of [35S]- 
methionine/ml of methionine-free EC2. At the end of the 
labeling period, the cells were washed with phosphate- 
buffered saline (PBS), harvested by scraping, lysed in 
RIPA buffer (50 mM Tris-HCI, pH 8.0, 150 mM NaCI, 
0.5% sodium deoxycholate, 1% Nonidet P-40 [NP40], 1% 
sodium dodecyl sulfate [SDS]), and analyzed either di- 
rectly or after immunoprecipitation on a 10% SDS-poly- 
acrylamide gel (SDS- PAGE). Immunoprecipitations were 
performed using Pansorbin cells (suspension of fixed 
Staphylococcus aureus cells, Calbiochem) essentially as 
described by Zhu and Weller (1992). 
as described previously (Szil~gyi and Cunningham, 
1991). The envelope components of virions and L-parti- 
cles were solubilized and separated from the tegument/ 
capsid material by treatment with NP40 as described by 
McLauchlan and Rixon (1992). BriefLy, NP40 was added 
to the virion and L-particle preparations to a final concen- 
tration of 1%. Following incubation at 0°C for 20 min, the 
samples were centrifuged at 14,000 rpm for 15 min. The 
supernatants containing envelope proteins were re- 
moved and mixed with SDS-PAGE denaturing buffer 
(0.05 MTr is -  HCI, pH 6.7, 2% SDS, 5% 2-mercaptoethanol, 
10% glycerol, and 0.001% bromophenol blue) and stored 
at -20°C. The pellets containing tegument and capsid 
structures were washed three times in culture medium 
lacking phenol red and calf serum, resuspended in that 
medium, and stored at -20°C after addition of SDS- 
PAGE denaturing buffer. 
Purification of capsids 
BHK cells in roller bottles were infected at a moi of 10 
PFU/cell and incubated at 37°0 for 24 hr. Virus capsids 
were isolated and purified from nuclear lysates of in- 
fected cells in a 20-50% sucrose gradient as described 
by Booy et al. (1991) and Tatman et aL (1994). Following 
centrifugation, individual capsid bands were removed 
from the gradient with a syringe, diluted in 0.5 M NaCI, 
20 mM Tris-HOl, pH 7.4, 1 mM EDTA (NTE), pelleted, 
and resuspended in a small volume of NTE as described 
by Booy etaL (1991). The capsids used in this study were 
examined under electron microscope and found to be 
homogeneous and free from contaminating noncapsid 
material. HSV-1 type B capsids were extracted with gua- 
nidine hydrochloride as described by Newcomb and 
Brown (1991). To prepare radiolabeled capsids, BHK 
cells in roller bottles were infected with 10 PFU/cell of 
wt HSV-1 in EC2. At 6 hr postinfection, the cells were 
washed with methionine-free EC2 and labeled in that 
medium with 25 #Ci/ml of [36S]methionine for 16 hr. Nu- 
clear lysate of infected cells was subjected to 20-50% 
sucrose gradient ultracentrifugation as described above. 
Eight-drop (approximately 300 #1) fractions from below 
the type C capsid band to the top of the gradient were 
collected. Aliquots of each fraction were TCA precipi- 
tated and radioactivity was measured by scintilation 
counting. 
Purification of virions and L-particles of HSV-1 
BHK cells in 10 roller bottles were infected at a m.o.i. 
of 0.002 PFU/cell and incubated at 37°C for 4 to 5 days 
until CPE was complete. Extracellular virus was har- 
vested, subjected to velocity gradient centrifugation on 
5 to 15% Fieoll gradients, and bands corresponding to 
virions and L-particles were collected and concentrated 
DNA manipulations 
The UL60RF is located between nucleotide positions 
15132 to 17160 of the HSV-1 genome (Fig. la; McGeoch 
et aL, 1988). Nucleotide sequences carrying the UL6 
gene and a portion of UL7 gene (position 14590 to 17675; 
Fig. la) were inserted between the EcoRI and the BamHI 
sites of pAT153 forming pAS21. A 256-bp Nael fragment 
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(position 15756 to 16011; Fig. la)located within the UL6 
ORF was deleted from pAS21 to give pAS213. 
For expression in Escherichia ceil, nuoleotide se- 
quences from 10 bp upstream (position 15122) from the 
ATG start codon of UL6 to the Sail site at position 17323 
(Fig. la) were cloned in frame into the coding sequences 
of six histidine residues of the E. coil expression vector 
pQE30 (QIAGEN Inc.) to form pAS20. This gene fusion 
construct consists of 6 codons of histidine residues (6 
x His), 6 codons from the 5' nontranslated region of the 
UL6 gene, and all 676 codons of the UL6 gene. The 
expression of 6XHis-tagged UL6 protein is regulated by 
isopropyk/3-D-thiogalactopyranoside (IPTG)-inducible /ac 
operator sequences and a phage T6 promoter. The 
translation is expected to terminate at the UL6 TGA stop 
codon. Plasmid pAS20 was transformed into E. coil strain 
M15[pREP4] (QIAGEN Inc.) which, following induction 
with IPTG, expressed large quantities of 6XHis-tagged 
UL6 fusion protein in an insoluble form. Purification of 
the fusion protein under denaturing conditions by metal 
chelate chromatography according to manufacturer's in- 
struction resulted in extremely low recovery of the pro- 
tein. Therefore, inclusion bodies of E. coil strain 
M15[pREP4] (QIAGEN Inc.) carrying pAS20 were pre- 
pared as described (Harlow and Lane, 1988). This prepa- 
ration consisting predominantly of 6XHis-UL6 protein 
(approximately 80% of the total protein) was used for 
immunization purposes (see below). 
To express UL6 in vaccinia virus, the HSV-1 sequences 
present in pAS20 were inserted into the vaccinia virus 
vector pMJ601 (Davison and Moss, 1990) such that the 
UL6 gene was placed under the control of the synthetic 
late promoter of vaccinia virus. Here the translation is 
expected to be initiated at the UL6 ATG start codon. This 
construct was inserted into the thymidine kinase gene 
of the vaccinia virus strain WR by homologous recombi- 
nation, and three independent plaque isolates of recom- 
binant vaccinia virus were selected as described by Davi- 
son and Moss (1990). All three isolates expressed HSV- 
1 UL6 polypeptide, and one such virus, V-UL6, was used 
in experiments described in this paper. 
RNA isolation and Northern blot analysis 
BHK cells were mock-infected or infected with HSV-1 
in the presence or absence of PAA at 10 PFU/cell and 
total cellular RNA was extracted at 6 hr postinfection 
as described (Maniatis et aL, 1982). For Northern blot 
analysis, the RNA was fractionated on a 1.2% agarose- 
formaldehyde gel and transferred to Hybond-N mem- 
brane (Amersham) according to Maniatis et aL (1982). 
Hybridization was performed using appropriate 32p-la- 
beled probes as described (Patel and EIliott, 1992). The 
double-stranded DNA probes used for hybridization were 
nick translated using [32P]dCTP. To prepare a single- 
stranded probe, a 5' end-labeled oligonucleotide com- 
plementary to sequences coding for the N-terminal 
amino acids of UL7 gene was hybridized to denatured 
pAS213 and extended as described below. The DNAwas 
cleaved with Ncol (Fig. la), and the labeled single- 
stranded fragment was isolated from alkaline agarose 
gel (Greene, 1988). 
Sl nuclease and primer extension analysis 
This was performed as described by Kingston (1987). 
To prepare probes for Sl mapping, 5' end-labeled 30-mer 
oligonucleotides complementary to nucleotide sequences 
coding for the N-terminal 10 amino acids of the genes UL6 
and UL7 of HSV-1 were synthesized. The oligonucleotides 
were hybridized to denatured plasmid pAS213 and ex- 
tended using a Klenow fragment of E. coil DNA polymer- 
ase I. The DNA was cut to appropriate lengths using BspHI 
(for UL6-specific probe; Fig. l a) or Dral (UL7-specific 
probe; Fig. la) and the labeled single-stranded DNA frag- 
ments were isolated using alkaline agarose gel electro- 
phoresis (Greene, 1988). For primer extension analysis, 
5' end-labeled 30-mer oligonucleotides complementary to 
nucleotides 49 to 78 (coordinates 14980 to 15009; UL6) 
and 56 to 85 (coordinates 17014 to 17043; UL7) down- 
stream from the initiation site (as determined by $1 map- 
ping) of UL6 and UL7 mRNAs were used. The reaction 
products were analyzed on a 6% polyacrylamide urea se- 
quencing gel. To determine the exact sizes of the bands, 
dideoxy sequencing ladders of the bacteriophage M13 
DNA were electrophoresed on adjacent lanes. 
Preparation of antiserum 
Antisera were produced in two rabbits by immunization 
with an emulsion containing approximately 0.7 mg of E. 
ceil-expressed 6XHis-tagged @L6 in the form of insolu- 
ble inclusion body preparation (see above) in Freund's 
complete adjuvant. Subsequent boosts used Freund's in- 
complete adjuvant and 0.7 mg of the inclusion body prep- 
aration. A total of five booster injections were given each 
at 3-week intervals after primary injection, Eleven days 
after the last boost, rabbits were bled out and antisera 
prepared. The experiments described in this paper used 
one antiserum, 2C2. Both the preimmune and immune 
antisera were extensively adsorbed against acetone 
powder of uninfected BHK cells prior to use as described 
by Harlow and Lane (1988). 
SDS-PAGE and Western blotting 
Proteins were fractionated on 9% (or as indicated) poly- 
acrylamide gels cross-linked with 2% (wt/wt) N,N'-meth- 
ylenebisacrylamide, and detected by either autoradiogra- 
phy or silver staining as described (McLean et al., 1990). 
For Western immunoblotting, proteins were electropho- 
retically transferred to Hybond ECL membranes (Amer- 
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FIG. 1. (a) Schematic representation of the HSV-1 genome showing the location of the UL6 and UL7 genes. The relevant nucleotide positions 
and restriction sites are shown. B, Bs, D, H, N, Nc, and S refer to restriction sites Bglll, BspHI, Dral, Hindlll, Nael, Ncol, and Sail, respectively. The 
probes used in Northern blot analysis (b) are indicated by solid lines. Probes A and B correspond to the Hindlll to Sail fragment of the LIL6 gene 
and the Sail fragment of the UL7 gene, respectively. Probe C represents the single-stranded probe complementary to the coding strands of the 
UL6 and UL7 genes. The location and direction of the 3.3- and 1.3-kbp transcripts are shown. (b) Northern blot analysis of the UL6 and UL7 
transcripts. Total cellular RNA from BHK cells mock-infected (MI) or infected with HSV-1 (I) in the presence (+) or absence (-) of PAA was hybridized 
with 3Zp-labeled probes A, B, or C (see Fig. la). The positions of the 3.3- and 1.3-kbp transcripts are shown. 
sham) as described by Towbin et al, (1979). Membranes 
were incubated with 1,200 dilution of serum, and the immu- 
noreactive proteins were detected using protein A conju- 
gated to horseradish peroxidase (Sigma) and enhanced 
chemilumenescence detection reagents (Amersham). 
RESULTS 
Northern blot analysis 
HSV-1 genes UL6 and UL7 are located near the left 
end of the unique long region of HSV-1 genome (Fig. l a; 
McGeoch et al., 1988). The putative UL70RF  overlaps 
UL6 at its 5' end; the translational start site of UL70RF  
is 23 bp upstream of the UL6 stop codon. The transla- 
tional start sites of genes UL5 and UL6 are located within 
one nucleotide of each other, but are coded by opposite 
strands (Fig. la; McGeoch et aL, 1988). Two hypothetical 
transcripts coterminal at their 3' ends have been pre- 
dicted for UL6 and UL7 genes from nucleotide sequence 
analysis (McGeoch et al., 1988). To identify and analyze 
the expression of the UL6 and UL7 transcripts, total cell 
RNA was isolated from mock-infected or HSV-l- infected 
cells at 6 hr postinfection and subjected to Nor[hem blot 
analysis. As shown in Fig. l b, a UL6-specific double- 
stranded DNA probe (probe A) identified a transcript of 
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approximately 3.3 kb, whereas a UL7-specific double- 
stranded DNA probe (B) hybridized to transcripts of 3.3 
and 1.3 kb. The same two transcripts were detected 
when infected cell RNA was probed with a single- 
stranded DNA probe (C) complementary to the coding 
sequences of both the UL6 and the UL7 genes, confirm- 
ing the rightward orientation of the two transcripts (Fig. 
lb). These results show that the 1.3-kb transcript is colin- 
ear with the 3' portion of the 3.3-kb transcript, and they 
are consistent with the hypothetical transcripts predicted 
from the nucleotide sequence (McGeoch et al., 1988). 
The larger transcripts seen hybridizing with all three 
probes probably represent readthrough products of the 
UL6 and UL7 mRNAs occurring due to inefficient utiliza- 
tion of the polyadenylation site located at the 3' end of 
the UL7 gene (McGeoch et al., 1988). The 1.3- and 3.3- 
kb transcripts were also found in RNA made from cells 
infected with HSV-1 in the presence of PAA, although in 
reduced quantities (Fig. l b), indicating that viral DNA 
replication is required for maximum gene expression. 
Sl nuclease and primer extension analysis 
To map the 5' initiation sites of the UL6 and UL7 
mRNAs, $1 nuclease analysis was carried out using ra- 
diolabeled probes that spanned the putative 5' end of 
the respective genes. As shown in Fig. 2a, a single DNA 
band of 230 nucleotides (nt) for the UL6-specific probe 
and three bands of 205, 207, and 208 nt for UL7-specific 
probe were protected with RNA isolated from HSV-1- 
infected cells (Fig. 2a). These results are consistent with 
transcription beginning at 200 nt (UL6) and 175, 177, and 
178 nt (UL7) upstream from the ATG star codons of the 
UL6 and UL70RFs (Figs. 2a and 2c). 
Primer extension analysis to map the 5' termini of 
these two transcripts confirmed the results obtained in 
Sl nuclease experiments. As shown in Fig. 2b, several 
extended products of between 78 to 81 nt (UL6) and 83 
to 87 nt (UL7) were identified. The largest of these prod- 
ucts is consistent with transcription beginning at 203 
(UL6) and 180 (UL7) nt upstream from the ATG star co- 
dons (Figs. 2b and 2c). These results are in close 
agreement with the results obtained by $1 nuclease anal- 
ysis (Fig. 2a). The possible TATA box for the two genes 
are shown (Fig. 2c). 
Expression of UL6 in vaccinia virus 
To express the HSV-1 gene UL6 in a heterologous 
system, a recombinant vaccinia virus, V-UL6, was con- 
structed. The synthesis of viral polypeptides in BHK cells 
infected with wild type (wt) HSV-1, V-UL6, and the paren- 
tal vaccinia virus strain WR was examined. Infected cells 
were labeled with [35S]methionine and analyzed on SDS- 
PAGE. The results show that V-UL6 synthesized a novel 
protein with an approximate Mr of 75 kDa (Fig. 3, lane 
3). This is in close agreement with the Mr of 74,087 pre- 
dicted for the UL60RF (McGeoch et al., 1988). This pro- 
tein was not present at a detectable level in HSV-I-in- 
fected cell extracts (Fig. 3, lane 2). A slightly slower mi- 
grating protein band was seen in HSV-l-infected cells 
(lane 2), but it is probably a host protein as it was also 
found in mock-infected cells (lane 1), 
Detection of the UL6 gene product in HSV-infected 
cells 
To identify the UL6 gene product in infected cells, a 
polyclonal antiserum (2C2) was raised against an E. coi l-  
expressed 6×His~tagged UL6 protein (see Materials and 
Methods). The [3~S]methionineqabeled infected cell pro- 
teins described above were immunoprecipitated with 
preimmune or immune antisera 2C2 and analyzed on 
SDS-PAGE (Fig, 3, lanes 5 to 12). Immune serum 2C2 
precipitated the 75-kDa UL6 protein synthesized by the 
vaccinia virus recombinant V-UL6 (lane 7). A minor pro- 
tein of the same mobility was also immunoprecipitated 
from HSV-l-infected cell extracts (lane 6) but not from 
vaccinia strain WE-infected (lane 8) or mock-infected 
(lane 5) cells. The results show that the UL6 protein is 
expressed at comparatively low levels in HSV-l-infected 
cells. The preimmune 2C2 serum failed to recognize the 
UL6 protein in HSV-l-infected cells (lane 10), although it 
reacted weakly with the overexpressed UL6 in V-UL6- 
infected cells (lane 11). The cross-reactive bands seen 
in lanes 6 and 7 may be due to nonspecific precipitation 
by the antiserum. Alternatively, at least in the case of 
HSV-l-infected cell extract (lane 6), some of the cross- 
reacting proteins may be coimmunoprecipitated possibly 
because they interact with the UL6 protein. 
We next examined the reactivity on Western blot of the 
antiserum 202 with infected cell proteins. As shown in 
Fig. 4a, the immune serum detected the UL6 polypeptide 
from V-UL6- and HSV-lqnfected cells but not from mock- 
or WR-infected cells. The UL6 protein was not recognized 
by the preimmune serum (Fig. 4a). As with the immuno- 
precipitation experiment above, the low intensity of the 
UL6 band in HSV-l-infected cells suggests that this pro- 
tein is expressed at relatively low levels in infected cells. 
The 202 serum cross-reacted with proteins that migrate 
close to but at a slower rate than the UL6 protein (Fig. 
4a). To minimize these nonspecific reactions, a combina- 
tion of immunoprecipitation and-immunoblotting experi- 
ments was performed. Cell extracts from mock-infected 
cells or cells infected with V-UL6, vaccinia virus strain 
WR, wt HSV-1 (in the presence or absence of PAA), or 
a viral DNA replication-negative mutant of HSV-1, HSV- 
lambUL8, were immunoprecipitated with antiserum 2C2. 
The immune complexes were subjected to SDS-PAGE 
and analyzed on a Western immunoblot using the same 
antiserum (Fig. 4b). A series of twofold dilutions of the 
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FIG. 2. Mapping of the 5' end of the UL6 and UL7 transcripts. (a) $1 nuclease analysis was performed using appropriate 5' end-labeled probes 
(see Materials and Methods) that were hybridized to total cellular RNA isolated 6 hr postinfection from mock-infected (MI) or HSV-l-infected (I) BHK 
ceils. The hybrids were digested with $1 nuclease and the protected fragments were fractionated on a 6% polyacrylamide/9 M urea sequencing 
gel. T, C, G, A, dideoxy sequencing ladder of bacteriophage M13 DNA used as size markers. Numbers indicated by arrows represent he size of 
$1 nuclease protected fragments. (b) Primer extention analysis was carried out by hybridizing appropriate 5' end-labeled primers (see Materials 
and Methods) to total cellular RNA from mock-infected (MI) or HSV-l-infected (I) BHK cells. The primers were elongated using AMV reverse 
transcriptase. The extended products were analysed in parallel with the M13 dideoxy sequencing ladders (T, C, G, A) as described in (a). The sizes 
of the extended products are indicated. (c) The nucleotide sequence adjacent to the 5' termini of the UL6 and UL7 mRNAs. The position of the 
potential TATA box relative to the first transcription initiation site of the UL6 and UL7 mRNAs is underlined. 
immune complexes of HSV-infected cell extracts were 
analyzed in this experiment. The UL6 protein was de- 
tected not only in V-UL6- and wt HSV-l-infected cells, 
but also in cells infected under conditions in which the 
viral DNA synthesis was blocked either by adding PAA 
to the medium, or by using the mutant virus HSV-lamb- 
UL8 (Fig. 4b). The second band seen in this experiment 
is the immunoglobulin protein (IgG) from the immune 
complexes. HSV-lambUL8 virus carries an amber non- 
sense stop codon inserted in frame by site-directed mu- 
tagenesis at codon 267 of gene UL8 (unpublished data) 
which encodes a protein that is essential for viral DNA 
replication in infected cells (Carmichael and Weller, 
1989). In noncomplementing cells this virus does not 
synthesize viral DNA and therefore is unable to replicate 
(data not shown). These results are consistent with the 
Northern blot data shown above where the UL6-specific 
transcript was detected in cells infected in the presence 
of PAA (Fig. l b). As with the transcript, the quantity of 
the UL6 protein was somewhat reduced (Fig. 4b) under 
these conditions, suggesting that viral DNA synthesis is 
required for maximum gene expression. Analysis of the 
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kDa 
200 
UL6 protein expressed in V-UL6-infected cells was found 
in virions, but not in L-particles, of HSV-1 (lanes 1 to 3). 
The virion location of the UL6 protein was further con- 
firmed by analysis of fractions across a Ficoll gradient 
containing HSV-1 preparation by Western immunoblot- 
ting which showed that this protein cofractionated with 
the virions, but not L-particles (data not shown). The anti- 
serum cross-reacted mainly with larger proteins of HSV- 
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FIG. 3. SDS-PAGE analysis of the proteins synthesized in infected 
cells, BHK cells were mocbinfected (MI) or infected with HSV-1, V- 
LJL6, or vaccinia virus strain WR at 10 PFU/celI. Proteins were labeled 
with [~S]methionine from 6 to 24 hr postinfection (mock- or HSV-1- 
infected cells) or 6 to 8 hr postinfection (WR- or V-UL6-infected cells). 
0all extracts were analyzed either directly or after immunoprecipitation 
(IP) with preimmune (PI) or immune (I) 202 sera on a 10% polyacryl- 
amide gel. The position of the UL6 proteins is indicated by an arrow. 
The migration of protein size markers is shown at the right. 
b 
HSV-1 HSV-1/PAA ambUL8 
MI ~ WRI tl ~t t 
time course of UL6 synthesis in HSV-l-infected cells 
showed that the protein could be detected as early as 2 
hr postinfection (data not shown). We have recently iso- 
lated an HSV-1 mutant carrying a lacZ insertion in the 
UL6 gene. As expected, the UL6 protein was not detected 
by antiserum 202 in the mutant-infected cells (unpub- 
lished data). 
Analysis of purified virus particles 
To determine if the UL6 protein is a component of virus 
particles, virions and L-particles released from BHK cells 
infected with wt HSV-1 were purified in a 5-15% Ficoll 
gradient using the method of Szil~figyi and Cunningham 
(1991). Approximately 2 X 10 e purified particles were 
analyzed on a Western immunoblot with antiserum 202. 
As shown in Fig. 5a, a protein that comigrated with the 
UL6~ 
IgG 
FIG. 4. Western immunoblotting of infected cell proteins. (a) BHK 
cells were mock-infected (MI) or infected with HSV-1, V-UL6, or vaccinia 
virus strain WR at 10 PFU/cell. At 18 hr postinfection the medium was 
removed and the cells were suspended in SDS-PAGE denaturing 
buffer. Proteins from each sample were subjected to SDS-PAGE and 
analyzed by immunoblotting with 13reimmune (PI) or immune (I) 202 
sere. Arrows indicate the position of the UL6 protein, (b) Expression 
of the UL6 protein in the absence of viral DNA replication. BHK cells 
were mock-infected (Mr) or infected with V-UL6, vaccinia strain WR, wt 
HSV-1 (in the presence or absence of PAA), or ambUL8 virus at 10 
PFU/cell for 18 hr. Infected cell proteins were immunoprecipitated with 
antiserum 202. The immune complexes were subjected to SDS-PAGE 
and analyzed by immunoblotting with antiserum 202. The positions of 
the UL6 protein and lgG are indicated, 
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FIG. 5. Immunoblot analysis of virus particles. Proteins were subjected to SDS-PAGE and analyzed by immunoblotting. As indicated, immunoprecipi- 
tated cell extracts (with antiserum 202) from V-UL6-infected cells, wt HSV-l-infected cell extract (OE), purified virions (V) and L-particles (L) of wt 
HSV-1 and strain R(F)UL46/47A2, envelope (E) and tegument (T) components of wt HSV-1 virions, purified type A, B, C capsids of wt HSV-1, and 
type B capsids of ambUL8 virus were analyzed using antisera (a) 202 (UL6), (b) Z1 F11 (65KDBp), (C) 94497 (VP13/14), or (d) LP1 (VP16). The relative 
cross-reactive proteins in (a) are highlighted. 
1 virions and L-particles (Fig. 5a, lanes 2 and 3, B, O) 
and also with a lower molecular weight protein (lanes 2 
and 4, ©). Analysis of the polypeptide profiles of HSV-1 
virions and L-particles on SDS-PAGE (not shown) sug- 
gested that the larger cross-reacting proteins may be 
VPll/12 (also known as 92/91K; Fig. 5a, B) and VP13/ 
14 (82/81 K; Fig. 5a, O) tegument proteins of virion and L- 
particles encoded by genes UL46 and UL47, respectively 
(McLean eta/., 1990; McLauchlan and Rixon, 1992; Zhang 
and McKnight, 1993). To test this possibility, virions and 
L-particles of a double-deletion mutant of HSV-1 strain F, 
R(F)UL46/47A2, carrying deletions which remove genes 
UL46 and UL47 (Zhang and McKnight, 1993), were ana- 
lyzed on the same immunoblot (Fig. 5a, lanes 4 and 5). 
The antiserum recognized the UL6 protein in the virions, 
but not L-particles, of strain R(F)UL46/47A2 although, as 
expected, the cross-reacting proteins VP11/12 and VP13/ 
14 were not detected (lanes 4 and 5). The continued 
presence of the lower molecular weight protein (lane 4, 
©) shows that it is not a degradation product of VP11/ 
12 or VP13/14. The small amount of UL6 protein seen in 
L-particle preparations in Fig. 5a (lanes 3 and 5) is due 
to virion contamination; Ficoll gradient produced virions 
and L-particle preparations are known to be cross-con- 
taminated at low levels (Szil~gyi and Cunningham, 1991; 
McLauchlan and Rixon, 1992). 
UL6 is associated with virus capsids 
The fact that the UL6 protein is a component of virions 
and not L-particles suggested a possible association of 
this protein with the virus capsid. To test this possibility, 
NP40-treated purified wt HSV-1 virion preparations, and 
virus capsids (approximately 2 x 109 ) purified from BHK 
ceils infected with either the wt HSV-1 or the HSV-lamb- 
UL8 virus were analyzed on the same immunoblot (Fig. 
5a, lanes 6 to 11). In contrast o the three types of capsids 
(types A, B, and C; see Introduction) synthesized by wt 
HSV-1 in infected cells, viral DNA replication-negative 
mutants (such as ambUL8) synthesize only type B cap- 
sids under nonpermissive growth conditions (Sherman 
and Bachenheimer, 1988). The location of the UL6 protein 
within the virion was examined by treatment of wt HSV- 
1 virions with N P40 followed by centrifugation to separate 
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envelope proteins from the tegument and capsid struc- 
tures (see Materials and Methods). As shown in Fig. 5a 
(lanes 6 and 7), the UL6 protein was exclusively present 
in the tegument/capsid fraction. Furthermore, all three 
types of wild type HSV-1 capsids and type B capsids 
made by the DNA-negative mutant ambUL8 under non- 
permissive conditions (i.e., when grown on noncomple- 
menting BHK cells) were found to contain the UL6 protein 
(Fig. 5a, lanes 8 to 11). The quantity of the UL6 protein 
found in the capsids was comparable to that in the viri- 
ons. The slightly faster mobility of the UL6 protein in the 
tegument/capsid fraction (lane 7) compared to that seen 
in the virion and capsid preparations is due to local dis- 
tortion in the gel which was not observed in other experi- 
ments. The lower molecular weight protein seen in the 
capsid and virion preparations probably represents a 
breakdown product of the UL6 protein (Fig. 5a, O, lanes 
2,4, and 7 to 11). 
To rule out the possibility that UL6 is a tegument (or 
a nonstructural) contaminant present in the capsid prep- 
arations, the presence in the capsids of three "noncap- 
sid" proteins was examined, 65 K DNA binding protein 
(65KDBp), a major protein found predominantly in infected 
cell nuclei (Schenk etaL,  1988), and VP13/14 and VP16, 
both abundant virion tegument proteins (McLean et al., 
1990; Roizman and Furlong, 1974; Szil~gyi and Cunning- 
ham, 1991; McLauchlan and Rixon, 1992). HSV-l-infected 
cell extract or approximately 2 × 109 capsids or virions 
used in Fig. 5a were analyzed by Western immunoblot- 
ting using antibodies against the 65KDBp (monoclonal 
Z1F11, Schenk et al., 1988), VP13/14 (rabbit antiserum 
94497, McLean et aL, 1990), or VP16 (monoclonal LP1, 
McLean et al., 1982). The antibodies Z1F11 and 94497 
failed to detect the 65KDB P and VP13/14, respectively, in 
all the capsid preparations tested (Fig. 5b, lanes 2 to 5; 
Fig. 5c, lanes 5 to 8). As expected, Z1F11 detected the 
65KDBP in infected cells (Fig. 5b, lane 1), whereas anti- 
body 94497 recognized VP13/14 in the virions (Fig. 5c, 
lane 1), and the tegument/capsid fraction of virions of wt 
HSV-1 (lane 4), but not in the virions of strain R(F)UL46/ 
UL47A2 (lane 2). The antibody LP1 identified VP16 in 
abundance in virions of strain R(F)UL46/UL47Z&2 as well 
as wt HSV-1 and also in the tegument/capsid and enve- 
lope fractions of wt virions (Fig. 5d, lanes 1 to 4). The 
presence of VP16 in the envelope fraction of virus parti- 
cles has been observed previously and is thought to be 
due to partial sotubilization of this protein with NP40 
(McLaughlan and Rixon, 1992; Visalli and Brandt, 1993). 
Surprisingly, VP16 was found in the wt HSV-1 capsid 
preparations (Fig. 5d, lanes 5 to 7), although in vastly 
reduced quantities as compared to that in the virions 
(lanes 1 to 4), and it was barely detectable in the type 
B capsids synthesized in BHK cells by strain ambUL8 
(lane 8). 
The results of Fig. 5 were verified by fractionation of 
a capsid gradient. [35S]methionine-fabeled nuclear lysate 
of wt HSV-l-infected cells was subjected to sucrose den- 
sity gradient centrifugation and fractions were collected 
as described under Materials and Methods. The radioac- 
tivity profile and SDS-PAGE analysis of these fractions 
identified the position of types A, B, and C capsid bands 
in the gradient (Figs. 6a, 6b). Thus, fractions 3, 10, and 
14 corresponded to peaks consisting of types C, B, and 
A capsids, respectively (Figs. 6a, 6b). Western immu- 
noblotting of the fractions using antiserum 2C2 revealed 
that the UL6 protein was predominantly present in frac- 
tions 3 to 5 (representing C capsids), 9 to 13 (B capsids), 
and fraction 14 (A capsids) (Fig. 6c). The UL6 protein was 
not detected beyond fraction 14, although a small amount 
was seen at the top of the gradient in fraction 28 (Fig. 
6c). The fractions were also analyzed by Western immu- 
noblotting for 65KDaP, VP13/14, and VP16. Consistent with 
the results in Figs. 5b and 5c, antibodies Z1F11 and 
94497 failed to detect 65KDBp and VP13/14, respectively, 
in fractions 1 to 21, although these proteins were found 
in minute quantities in fractions 22 to 28 at the top of the 
gradient (not shown). Interestingly, probing for VP16 with 
antibody LP1 revealed that this protein was present 
throughout the gradient (Fig. 6d). These data strongly 
indicate that the small quantity of VP16 found in the puri- 
fied capsid preparations in Fig. 5c represent not a tegu- 
ment contaminant, but residual VP16 present due to this 
protein smearing through the gradient. 
Treatment of purified capsid with guanidine hydrochlo- 
ride (GuHCI) has been shown to result in selective solubi- 
lization of some of its proteins (Newcomb and Brown, 
1991; Newcomb et al., 1993). To test the effect on the 
UL6 protein of GuHCI treatment Of capsids, wt HSV-1 type 
B capsids were extracted with various concentrations of 
GuHCI and analyzed by SDS-PAGE and Western immu- 
nobiot. As shown in Fig. 7a, proteins VP21, VP22a, VP24, 
and VP26 were removed either completely or nearly so 
by treatment with 2 M GuHCI; capsids were completely 
solubilized at 3 M GuHCI (Fig. 7a). This is in close 
agreement with the results obtained by Newcomb and 
Brown (1991). Interestingly, Western immunoblotting of 
the same GuHOl-treated capsid preparations showed 
that the UL6 protein could be detected at or below 2 M 
GuHCI without significant loss, if any, in quantity, indicat- 
ing that this protein is tightly associated with the capsids 
(Fig. 7b). 
The silver-stained protein profiles of the same purified 
virions and L-particles of wt HSV-1 and capsids of wt 
HSV-1 and ambUL8 virus used in Fig. 5a were compared. 
Also included in this experiment were NP40-soluble and 
-insoluble fractions of virions and L-particles. The protein 
profiles of virions and L-particles (Fig. 8) were consistent 
with those described previously (Szil~gyi and Cunning- 
ham, 1991; McLauchlan and Rixon, 1992). Thus, the HSV 
glycoproteins (e.g., VP7, VP8, and VP17, better known as 
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FIG. 6. Sucrose gradient ultracentrifugation of intranuclear capsids. (a) Nuclear lysate of [35S]methionine-labeied wt HSV-l-infected cells was 
subjected to 20-50% sucrose gradient centrifugation. Twenty-eight fractions were collected, and radioactivity in each was measured as described 
under Materials and Methods. The positions of A, B, and C capsids are indicated. (b) Polypeptide profiles of fractions 1 to 28 shown in (a) on SDS- 
PAGE. The positions of capsid proteins are indicated. (c, d) Immunoblot analysis of fractions 1 to 28 shown in (a) using antiserum 2C2 (c) or LP1 
(d). V, Ficoli-purified HSV-1 virions. 
gB, gC, and gD, respectively) were found exclusively in 
the NP40-seluble fractions of virions and L-particles (Fig. 
8, lanes 3 and 6), whereas the tegument and capsid 
proteins were found in the insoluble fraction [e.g., VP13/ 
14 (82/81K) in the tegument of both virions and L-parti- 
cles, VP4 (or Vmw175) in L-particles tegument, and VP5 
and VP19C capsid proteins predominantly in the virions; 
lanes 2 and 5; McLean etaL, 1990; Szil~gyi and Cunning- 
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made under nonpermissive growth conditions by ambUL8 
virus (Fig. 8, lane 10). Like UL6, this protein was consis- 
tently found not in the L-particles, but in the tegument of 
the virions (lanes 1 and 2, I~). One possibil ity is that it 
is a degradation product of the major capsid protein, 
VP5. However, at present we cannot completely rule out 
that it is a separate protein also associated with the 
capsids. 
DISCUSSION 
We describe the transcriptional analysis of the UL6 
and UL7 genes of HSV-1. We have also identified and 
characterized the UL6 gene product of HSV-1 in infected 
cells. The transcripts of the UL6 and UL7 genes were 
shown to be synthesized in HSV-l- infected cells, and 
their 5' ends were mapped by $1 nuclease and primer 
extension analysis. 
Avacc in ia  virus recombinant (V-UL6) carrying the HSV- 
1 UL6 gene synthesized a novel protein with an approxi- 
mate Mr of 75 kDa in infected cells, which is close to 
the Mr value of 74.087 kDa predicted from the UL60RF 
(McGeoch et al., 1988). A rabbit polyclonal antiserum 
t Capsids 
amb 
} HSV-1 t I HSV-1 i UL8 
V T E L T E A B C B 
FIG. 7. Analysis of GuHCI-extracted capsids. HSWl B capsids were 
extracted with various concentrations of GuHCI and subjected to (a) 
12% SDS-PAGE and (b) immunoblotting using antiserum 2C2. The 
positions of the capsid proteins in (a) and of UL6 in (b) are indicated. 
V-UL6, UL6 immunoprecipitated with antiserum 202 from V-UL6-in- 
fected cells. 
ham, 1991; McLauchlan and Rixon, 1992; Zhang and 
McKnight, 1993)]. The protein profiles of the capsids cor- 
responded to those described previously (see Introduc- 
tion). VP16 was not present at detectable levels in the 
capsid preparations (lanes 7 to 10), although small 
amounts of this protein were found in them by Western 
immunoblotting (Fig. 5d). The UL6 protein, which mi- 
grates sl ightly ahead of VP13/14 virion proteins (Figs. 
5a), was not present at a detectable level either in the 
virions or in the capsid preparations (Fig. 8, lanes 1 and 
7 to 10). A protein band was seen below the VP13/14 
bands in virions (Fig. 8, lane 1, O), but this is unlikely to 
be UL6 as it was also found in the L-particles (lane 4, 
O), Furthermore, this protein appears to be a component 
of the envelope of both virion and L-particles (Fig. 8, 
lanes 3 and 6). Interestingly, a protein of approximately 
70 kDa unrelated to UL6 was seen in A, B, and C capsids 
of wt HSV-1 (Fig. 8, lanes 7 to 9, ~1), although it was not 
present, at least at a detectable level, in the B capsids 
VP4 
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FIG. 8. Pelypeptide profiles of virions, L-particles, and capsids of 
HSV-1. Purified wt HSV-1 virions (V, lane 1), L-particles (L, lane 4) and 
their envelope (E) and tegument (T) components (lanes 2 and 3 and 5 
and 6, respectively), and purified types A, B, and C capsids of wt HSV- 
1 (lanes 7 to 9) and type B capsids of ambUL8 virus (lane 10) were 
fractionated on a polyacrylamide gel. The proteins were visualized by 
silver staining. Some of the known polypeptides of virions and L-parti- 
cles are indicated on the left, whereas those of the capsids are shown 
on the right. The relevant bands are highlighted by arrowheads or 
closed circles. 
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raised against an E. co~i-expressed 6xHis-UL6 fusion 
protein precipitated the UL6 protein expressed in V-UL6- 
and HSV-l-infected cells. The reactivity of the antiserum 
was more apparent in Western immunoblot analysis 
where it specifically identified the UL6 gene product in 
both HSV-1- and V-UL6-infected cells. The UL6 and UL7 
mRNAs, and the UL6 protein were expressed subopti- 
mally in the absence of viral DNA replication, indicating 
that viral DNA synthesis was required to achieve maxi- 
mum levels of expression. Thus, the UL6 and UL7 genes 
can be classified as delayed-early or ?'-1 genes, although 
a more detailed analysis of the kinetics of gene expres- 
sion is required to support this observation. 
Analysis of the purified virus particles showed that the 
UL6 protein was a component of virions but not of L- 
particles and that it was located exclusively in the tegu- 
ment/capsid fraction of the virion. As L-particles are 
known to lack virus capsids and DNA, and they share 
the tegument and envelope proteins with the virions, it 
seemed plausible that the UL6 protein was associated 
with virus capsids. Western immunoblot analysis of the 
purified types A, B, and C capsids of HSV-1, and the 
type B capsids synthesized by HSV-lambUL8 virus under 
nonpermissive growth conditions showed that this was 
the case. 
The possibility that the UL6 protein is a tegument or 
a nonstructural contaminant present in the capsid prepa- 
rations can be strongly discounted for the following rea- 
sons. The UL6 protein cofractionated with the viral cap- 
sids in a sucrose gradient. Noncapsid viral proteins such 
as the nuclear protein 65KDBp, and the tegument protein 
VP13/14 were not found in the capsid preparations. Al- 
though another tegument protein VP16 was detected in 
the capsid preparations, it was present in minute quanti- 
ties as compared to that found in the virions, and the 
amount of this protein varied with the type of capsids 
used. In the ambUL8-synthesized type B capsids VP16, 
which, like UL6, is also a ?'-1 product (Hall eta/., 1982), 
was barely detectable. The UL6 protein, in contrast, was 
present in virions and all the capsids in comparable 
amounts. Furthermore, analysis of the fractionated cap- 
sid gradient showed that, unlike UL6, VP16 smeared 
through the gradient, indicating that the presence of this 
protein in the purified capsids is due not to tegument 
contamination, butto the smearing of the gradient by this 
protein. Finally, the UL6 protein was not removed from 
the capsids by treatment with 2 M GuHCI, although the 
capsid proteins VP21, VP22a, VP24, and VP26 were se- 
lectively removed. Taken together these observations 
strongly indicate that the UL6 protein is a minor compo- 
nent of HSV-1 capsids. 
Apart from the seven known proteins that are thought 
to make up the capsid (see Introduction), to our knowl- 
edge no other virus (or cellular) proteins have so far 
been implicated with capsid structure. In this report, we 
unambiguously show that the UL6 gene product of HSV- 
1 is associated with the virus capsid. The nature of its 
association with the capsid is not clear. However, it is 
not required for capsid assembly. Recently, Tatman et 
al. (1994) and Thomsen et aL (1994) have demonstrated 
HSV-1 capsid assembly in insect cells infected with re- 
combinant baculoviruses expressing only the known 
capsid proteins. Our results show that the UL6 protein 
occurs in HSV-infected cells in very small amounts, with 
detection possible only by immunological means. This 
suggest&that he number of UL6 molecules associated 
per capsid is very low and probably explains why this 
protein has not previously been recognized in capsids. 
The locations in the capsid of most of the known capsid 
proteins have been examined (Trus et aL, 1992; New- 
comb and Brown, 1989, 1991; Newcomb et al., 1993). 
Newcomb and Brown (1991) have shown that treatment 
of capsids with 2 M GuHCI removed most, if not all, of 
pentons and the scaffolding proteins without significantly 
affecting the hexons. Consistent with these observations, 
our 2 M GuHCI-treated capsids were also found to lack 
the pentons (data not shown). The fact that the UL6 pro- 
tein was not removed from the capsids at 2 M GuHCI 
suggests that this protein is not part of the penton sub- 
unit. It appears to be more tightly integrated into the 
capsid shell. We are currently attempting to determine 
the location of the UL6 protein in the capsid. 
The precise functiOn of the HSV-1 UL6 protein remains 
unclear. Despite its apparent dispensability for capsid as- 
sembly, studies with the UL6 ts mutant, tsF18, show that 
this protein is required for cleavage and packaging of 
nascent viral DNA (Sherman and Bachenheimer, 1987). 
One line of circumstantial evidence that the UL6 gene 
product may associate with the virus capsid comes from 
the observations that in temperature-shift experiments 
comprising tsF18-infected cells, only the capsids assem- 
bled after the shift to permissive temperature participate in 
encapsidation of tsF18 DNA synthesized at NPT (Sherman 
and Bachenheimer, 1988). Our results are consistent with 
this hypothesis, and taken together they strongly indicate 
that the association of functional U L6 protein with the virus 
capsid is required for viral DNA cleavage and encapsida- 
tion. Furthermore, the results show that the interaction of 
the UL6 protein with the capsid is not a transient one, as 
this protein is found in mature virions. Exactly how the 
UL6 protein mediates its functions is not understood. We 
have recently constructed transformed cell lines express- 
ing the UL6 protein for isolation of virus carrying site- 
specific mutations in the UL6gene. Such mutants will be 
valuable in elucidating the role of UL6 in viral morphogen- 
esis and in determining the nature of its association with 
the capsids. 
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